Stay updated on EDP-305 Safety and Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the EDP-305 Safety and Efficacy in NASH Clinical Trial page.

Latest updates to the EDP-305 Safety and Efficacy in NASH Clinical Trial page
- Check2 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record details. The header and footer of ClinicalTrials.gov remain visible, indicating restricted access to the study entry.SummaryDifference19%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page now includes the 2019 NIH grant/contract attribution. The site revision has been updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page now displays an error indicating the content is unavailable, preventing access to the study details. Added study documents and metadata (Protocol PDF, SPA PDF, IPD plan, and related information) to provide additional resources when the page loads correctly.SummaryDifference98%

- Check45 days agoChange DetectedThe page now displays Revision: v3.6.5, signaling a newer site version, and the older Revision: v3.6.4 label has been removed.SummaryDifference18%

- Check60 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a minor update to the page’s documentation/version rather than to its content.SummaryDifference0.0%

- Check67 days agoChange DetectedFatty Liver Disease was replaced with Steatotic Liver Disease on the page to reflect updated nomenclature for liver fat–related conditions. This terminology change updates how the condition is described and searched within the study context.SummaryDifference0.0%

Stay in the know with updates to EDP-305 Safety and Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EDP-305 Safety and Efficacy in NASH Clinical Trial page.